RPS7 and hepatocellular carcinoma: Preclinical studies on human HCC cell lines (MHCC97H and HLE) and in orthotopic or experimental metastasis HCC mouse models showed that CRISPR/Cas9-mediated knockout of RPS7 led to reduced growth, migration, and invasion of tumor cells in vitro.